David Wei, PhD

Articles by David Wei, PhD

Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD

ByIra Shafran, MD,Hayley E. Young, PhD,David Wei, PhD,Patricia Burgunder, ARNP,Bruce P. Burnett, PhD,Gerald L. Klein, MD

April 20th 2016

This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.

Latest Updated Articles

Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:

David Wei, PhD

Articles by David Wei, PhD

Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD

Latest Updated Articles

Trending on Pharmacy Times

FDA Approves Reformulated Ranitidine After 5-Year Absence

Zuranolone Offers New Hope for Postpartum Depression

Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications

Updated Hypertension Guidelines Are Here

Fun Fact: Coffee Could Reduce Feelings of Depression